Advertisement · 728 × 90
#
Hashtag
#Setmelanotide
Advertisement · 728 × 90
Post image

CASE REPORT: Early setmelanotide in LEPR-deficient twins: psychomotor and metabolic outcome by Patricia Pigeon-Kherchiche et al

Obesity and Endocrinology, Volume 1, Issue 2, July 2025
Open access 👉 doi.org/10.1093/oben...

#obesity #setmelanotide #hyperphagia

1 1 0 0
Preview
Setmelanotide Safe, Efficacious in Treating Acquired Hypothalamic Obesity Setmelanotide was associated with significant weight reduction among patients aged 4 years and older with acquired hypothalamic obesity.

From #ENDO2025: #Setmelanotide was associated with significant #WeightReduction among adult and pediatric patients with acquired #HypothalamicObesity.

@endocrinesociety.bsky.social @ucsdhealth.bsky.social @themaximacenter.bsky.social @sickkidsto.bsky.social @childrensphila.bsky.social

1 0 0 0
Preview
Real-life experience on efficacy and safety of setmelanotide treatment in prepubertal children Abstract. Monogenic obesity, characterized by severe, early-onset obesity due to single-gene defects, often resists traditional weight management strategie

BRIEF REPORT Real-life Experience on Efficacy and Safety of #Setmelanotide Treatment in Prepubertal Children by Ahmet Kahveci et al

EJE Volume 192, Issue 2, February 2025
👉 doi.org/10.1093/ejen...
ESE Members free access via 👉 my.ese-hormones.org

#gonadotropin

2 1 0 0
Preview
Weekly Roundup - PHARMA - 6 January 2025 🔊BMS's Opdivo Qvantig FDA-Approved for Subcutaneous Use in NSCLC and Solid Tumors Bristol Myers Squibb's Opdivo Qvantig receives FDA approval for subcutaneous use in NSCLC and other solid tumors. The ...

Weekly Roundup - PHARMA - 6 January 2025

www.linkedin.com/pulse/weekly...

kstrategyand.com/pharma-news

#FDA #Hikma #GLP1 #Victoza #EliLilly #Zepbound #ObesityTreatment #RhythmPharma #Setmelanotide #Imcivree #GeneticObesity #Pfizer #Braftovi #Humanteconomy #Humantec #KStrategyand

0 0 0 0
Preview
Weekly Roundup - PHARMA - 30 December 2024 🔊FDA Approves Hikma's First Generic GLP-1 Injection for Type 2 Diabetes The FDA has approved the first generic daily GLP-1 injection for type 2 diabetes, referencing Novo Nordisk’s Victoza. The approv...

Weekly Roundup - PHARMA - 30 December 2024

Click here to read more ➡ www.linkedin.com/pulse/weekly...

kstrategyand.com/pharma-news

#FDA #Hikma #GLP1 #Victoza #EliLilly #Zepbound #ObesityTreatment #RhythmPharma #Setmelanotide #Imcivree #Humanteconomy #Humantec #KStrategyand

0 0 0 0